ICRF 159, (+/-) 1,2-DI(3,5-DIOXOPIPERAZIN-1-YL)PROPANE NSC-129,943 - RAZOXANE

被引：67

作者：

BAKOWSKI, MT ^{[1
]}

机构：

[1] WESTMINSTER HOSP,DEPT RADIOTHERAPY & ONCOL,LONDON SW1,ENGLAND

来源：

关键词：

D O I：

10.1016/S0305-7372(76)80007-2

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：95 / 107

页数：13

共 73 条

[61] SEVEN MJ, 1960, METAL BINDING MEDICI, P154
[62] MODE OF ACTION OF CYTOSTATIC AGENT ICRF-159
SHARPE, HBA
FIELD, EO
HELLMANN, K
[J]. NATURE, 1970, 226 (5245) : 524 - &
[63] MECHANISM OF ACTION STUDIES WITH IRCF 159 - EFFECTS ON GROWTH AND MORPHOLOGY OF BHK-21S CELLS
STEPHENS, TC
CREIGHTON, AM
[J]. BRITISH JOURNAL OF CANCER, 1974, 29 (01) : 99 - 100
[64] TUCKER DF, 1972, J NATL CANCER I, V48, P1347
[65] WAMPLER GL, 1974, P AM ASSOC CANC RES, V15, P189
[66] WASSERMAN TH, 1973, ICRF159 NAT CANC I D
[67] WEXLER H, 1969, CANCER, V23, P946, DOI 10.1002/1097-0142(196904)23:4<946::AID-CNCR2820230433>3.0.CO
[68] 2-U
[69] Windeyer B, 1966, Clin Radiol, V17, P32, DOI 10.1016/S0009-9260(66)80117-4
[70] WOODMAN RJ, 1974, CANCER CHEMOTH REP 2, V4, P45